Condition | Cancer

ECOG ACRIN E4512

  • IRB Number: ECOG ACRIN E4512
  • Contact Name: Lauren Jones, BS
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Mehul Patel, MD

Description

A Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

https://clinicaltrials.gov/ct2/show/NCT02201992